Estudio de extensión abierto del fármaco oral CEP-701 en pacientes con enfermedades malignas hematológicas y no hematológicas que han participado en un estudio clínico del CEP-701

To assess the safety and tolerability of long term administration of CEP 701 in patients with advanced malignancy.

Patients with hematologic and non hematologic malignancies who have participated in a clinical study of CEP 701 may participate in this extension study